Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.

Griesinger, Frank; Curigliano, Giuseppe; Subbiah, Vivek; Baik, Christina S; Tan, Daniel Sw; Lee, Dae H; Misch, Daniel; Garralda, Elena; Kim, Dong-Wan; van der Wekken, Anthonie J; Gainor, Justin F; Paz-Ares, Luis; Liu, Stephen V; Kalemkerian, Gregory P; Bowles, Daniel W; Mansfield, Aaron S; Lin, Jessica J; Smoljanovic, Vlatka; Rahman, Ahmadur; Zalutskaya, Alena; Louie-Gao, Melinda; Boral, Andy L; Mazières, Julien.

Future Oncol ; 20(6): 297-306, 2024 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-37916501

2.

Towards proactive palliative care in oncology: developing an explainable EHR-based machine learning model for mortality risk prediction.

Zhuang, Qingyuan; Zhang, Alwin Yaoxian; Cong, Ryan Shea Tan Ying; Yang, Grace Meijuan; Neo, Patricia Soek Hui; Tan, Daniel Sw; Chua, Melvin Lk; Tan, Iain Beehuat; Wong, Fuh Yong; Eng Hock Ong, Marcus; Shao Wei Lam, Sean; Liu, Nan.

BMC Palliat Care ; 23(1): 124, 2024 May 20.

Artigo em Inglês | MEDLINE | ID: mdl-38769564

3.

Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions.

Saw, Stephanie Pl; Ang, Mei-Kim; Tan, Daniel Sw.

Curr Treat Options Oncol ; 23(12): 1721-1731, 2022 12.

Artigo em Inglês | MEDLINE | ID: mdl-36451063

4.

Comparing the effect of a consult model versus an integrated palliative care and medical oncology co-rounding model on health care utilization in an acute hospital - an open-label stepped-wedge cluster-randomized trial.

Yang, Grace M; Zhou, Siqin; Xu, Zhizhen; Goh, Stella Sl; Zhu, Xia; Chong, Dawn Qq; Tan, Daniel Sw; Kanesvaran, Ravindran; Yee, Alethea Cp; Neo, Patricia Sh; Cheung, Yin-Bun.

Palliat Med ; 35(8): 1578-1589, 2021 09.

Artigo em Inglês | MEDLINE | ID: mdl-34524044

5.

Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.

Menzel, Michael; Kirchner, Martina; Kluck, Klaus; Ball, Markus; Beck, Susanne; Allgäuer, Michael; Assmann, Christin; Schnorbach, Johannes; Volckmar, Anna-Lena; Tay, Timothy Kwang Yong; Goldschmid, Hannah; Tan, Daniel Sw; Thomas, Michael; Kazdal, Daniel; Budczies, Jan; Stenzinger, Albrecht; Christopoulos, Petros.

J Pathol Clin Res ; 10(2): e354, 2024 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-38284983

6.

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.

Lin, Chia-Chi; Garralda, Elena; Schöffski, Patrick; Hong, David S; Siu, Lillian L; Martin, Miguel; Maur, Michela; Hui, Rina; Soo, Ross A; Chiu, Joanne; Zhang, Tian; Ma, Brigette; Kyi, Chrisann; Tan, Daniel Sw; Cassier, Philippe A; Sarantopoulos, John; Weickhardt, Andrew; Carvajal, Richard D; Spratlin, Jennifer; Esaki, Taito; Rolland, Fréderic; Akerley, Wallace; Deschler-Baier, Barbara; Rispoli, Lawrence; Samant, Tanay S; Chowdhury, Niladri Roy; Gusenleitner, Daniel; Kwak, Eunice L; Askoxylakis, Vasileios; De Braud, Filippo.

Oncoimmunology ; 13(1): 2290787, 2024.

Artigo em Inglês | MEDLINE | ID: mdl-38170160

7.

Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review.

Liu, Sibo; Tan, Daniel Sw; Graves, Nicholas; Chacko, Ann-Marie.

Appl Health Econ Health Policy ; 21(6): 841-855, 2023 11.

Artigo em Inglês | MEDLINE | ID: mdl-37747620

8.

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.

Nanjo, Shigeki; Wu, Wei; Karachaliou, Niki; Blakely, Collin M; Suzuki, Junji; Chou, Yu-Ting; Ali, Siraj M; Kerr, D Lucas; Olivas, Victor R; Shue, Jonathan; Rotow, Julia; Mayekar, Manasi K; Haderk, Franziska; Chatterjee, Nilanjana; Urisman, Anatoly; Yeo, Jia Chi; Skanderup, Anders J; Tan, Aaron C; Tam, Wai Leong; Arrieta, Oscar; Hosomichi, Kazuyoshi; Nishiyama, Akihiro; Yano, Seiji; Kirichok, Yuriy; Tan, Daniel Sw; Rosell, Rafael; Okimoto, Ross A; Bivona, Trever G.

J Clin Invest ; 132(13)2022 07 01.

Artigo em Inglês | MEDLINE | ID: mdl-35579943

9.

Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.

Shimizu, Toshio; Kim, Dong-Wan; Loong, Herbert H; Lin, Chia-Chi; Ng, Matthew Ch; Yamamoto, Noboru; Ma, Brigette; Tan, Daniel Sw.

Asia Pac J Clin Oncol ; 17(4): 388-395, 2021 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-33502085

10.

Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 study.

Tan, Daniel S-W; Leighl, Natasha B; Riely, Gregory J; Yang, James C-H; Sequist, Lecia V; Wolf, Juergen; Seto, Takashi; Felip, Enriqueta; Aix, Santiago P; Jonnaert, Maud; Pan, Chun; Tan, Eugene Y; Ko, Jinnie; Moody, Susan E; Kim, Dong-Wan.

Lancet Respir Med ; 8(6): 561-572, 2020 06.

Artigo em Inglês | MEDLINE | ID: mdl-31954624

11.

Improved Survival of Advanced Lung Cancer in Singapore Over the Past Decade.

Toh, Chee Keong; Ong, Whee Sze; Tan, Daniel Sw; Ng, Quan Sing; Kanesvaran, Ravindran; Fong, Kam Weng; Ang, Mei Kim; Tan, Eng Huat; Lim, Wan Teck.

Ann Acad Med Singap ; 46(9): 333-338, 2017 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-29022033

12.

Nucleolar localization of an isoform of the IGF-I precursor.

Tan, Daniel S-W; Cook, Alexandra; Chew, Shern L.

BMC Cell Biol ; 3: 17, 2002 Jul 02.

Artigo em Inglês | MEDLINE | ID: mdl-12095420

13.

Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors.

Molife, L Rhoda; Rudman, Sarah M; Alam, Salma; Tan, Daniel S-W; Kristeleit, Hartmut; Middleton, Gary; Propper, David; Bent, Liz; Stopfer, Peter; Uttenreuther-Fischer, Martina; Wallenstein, Gudrun; de Bono, Johann; Spicer, James.

Cancer Chemother Pharmacol ; 72(6): 1213-22, 2013 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-24085260

14.

Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference.

Tan, Daniel S-W; Gerlinger, Marco; Teh, Bin-Tean; Swanton, Charles.

Eur J Cancer ; 46(12): 2166-77, 2010 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-20413300

15.

Molecular profiling for druggable genetic abnormalities in carcinoma of unknown primary.

Tan, Daniel S-W; Montoya, Joey; Ng, Quan-Sing; Chan, Kian-Sing; Lynette, Oon; Sakktee Krisna, Sai; Takano, Angela; Lim, Wan-Teck; Tan, Eng-Huat; Lim, Kiat-Hon.

J Clin Oncol ; 31(14): e237-9, 2013 May 10.

Artigo em Inglês | MEDLINE | ID: mdl-23547070

16.

Truth about ERCC1 in lung cancer.

Tan, Daniel S-W; Ng, Quan-Sing; Tan, Iain B-H; Lim, Soon-Thye; Lim, Wan-Teck.

J Clin Oncol ; 28(10): e162; author reply e164, 2010 Apr 01.

Artigo em Inglês | MEDLINE | ID: mdl-20159806

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: